alvotech.com - ALVO Company profit before taxes, interest and amortization
Complex biosimilars and Icelandic production capacities create a significant defensive barrier for Alvotech (ALVO). The model is based on the production of affordable copies of blockbuster drugs, which guarantees high profitability following costly R&D. The use of proven formulas ensures rapid market capture upon patent expiration. The absolute EBITDA trend reflects current cash flow dynamics, where the 86.36 level captures the latest operating profit values.
Alvotech SA (ALVO) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
ALVO - Net Income|Future Net Profit Alvotech|ALVO - P/E Multiple|Projected Price to Earnings Ratio alvotech.com|ALVO - PEG Multiple|Enterprise Value to EBITDA Ratio Alvotech|ALVO - Operating profit EBITDA|Earnings per share for the trailing year Alvotech|ALVO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth alvotech.com|ALVO - Earnings per share growth in current year|Net earnings per share growth forecast for next year Alvotech
Analysis of all company metrics:Alvotech Biopharmaceuticals (ALVO)
The potential for scaling biosimilars in Iceland determines the financial stability of Alvotech, where the current value of 86.36 reflects the actual cash flow from core operations. EBITDA analytics demonstrate the volume of funds before interest payments, allowing investors to assess the company's ability to cover debt obligations and operating expenses amid the Fed's tight monetary policy.
Competitor analysis for Alvotech
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Liquidia Corporation (LQDA)|GLPG (glpg.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANIP (ANI Pharmaceuticals, Inc.)|Operating profit EBITDA MannKind Corp MNKD|AMPH - Profit before payment of interest, taxes and amortization|PCRX: Profit before payment of interest, taxes and amortization|SPRY (ARS Pharmaceuticals) - Operating profit before deduction of amortization|TBPH (theravance.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Aquestive Therapeutics, Inc.|Profit before interest, taxes and amortization scPharma SCPH|Operating profit before deduction of amortization TECX (Tectonic Therapeutic, Inc.)|Company profit before taxes, interest and amortization TNXP|Operating profit EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Eupraxia Pharmaceuticals, Inc. (EPRX) - Profit before interest, taxes and amortization|BioHarvest Sciences Inc. - Operating profit EBITDA|Invizyne Technologies (EXOZ) - Operating profit before deduction of amortization|ORMP: Operating profit EBITDA|Entera Bio - Income before deduction of interest, taxes and amortization|HYFT (MindWalk Holdings) - Operating profit EBITDA|Operating profit EBITDA abvcpharma.com|Profit before payment of interest, taxes and amortization Cumberland Pharmaceuticals Inc. (CPIX)|Profit before payment of interest, taxes and amortization QNTM (Quantum BioPharma Ltd.)|FibroGen Corp - Operating profit before deduction of amortization|Telomir Pharmaceuticals Corp - Profit before payment of interest, taxes and amortization|RANI - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Synergy CHC Corp|rallybio.com (RLYB) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization LEXX (Lexaria Bioscience Corp.)|PULM (Pulmatrix Corp) - Operating profit EBITDA|PTHL: Income before deduction of interest, taxes and amortization|Operating profit EBITDA APM|Operating profit EBITDA lyratherapeutics.com (LYRA)|Profit before payment of interest, taxes and amortization Impact BioMedical IBO|Income before deduction of interest, taxes and amortization TNFA|YCBD - Profit before payment of interest, taxes and amortization|PainReform Corp (PRFX) - Operating profit before deduction of amortization|CYTO: Operating profit EBITDA|lipella.com (LIPO) - Operating profit EBITDA|Operating profit before deduction of amortization OPTN|PIRS: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|PTPI - Profit before interest, taxes and amortization|Qilian International - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SLRN (acelyrin.com)|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
